Stockreport

AbbVie Targets Post Humira Growth With Cell Therapy And RINVOQ Expansion [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF AbbVie (NYSE:ABBV) has agreed to acquire Capstan Therapeutics to expand its work in in vivo CAR-T cell therapy. The company has also submitted upadacitinib (RINVOQ) f [Read more]